If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Applications of Biological Dosimetry Methods in Radiation Oncology, Nuclear Medicine, and Diagnostic and Interventional Radiology (MEDBIODOSE)
Closed for proposals
Project Type
Project Code
E35010CRP
2109Approved Date
Status
Start Date
Expected End Date
Completed Date
9 January 2025Participating Countries
Description
New title:Applications of biological dosimetry methods in radiation oncology, nuclear medicine, diagnostic and interventional radiology?Acronym: MEDBIODOSE?Biological dosimetry is one of the most developed branches of radiobiology; its technical aspects, particularly those relevant to cytogenetic assays, are well refined and have reached the level of the international standardisation. The aim of this CRP is to address various uses of biological dosimetry methods in radiation oncology, nuclear medicine, diagnostic and interventional radiology. It will include filing in gaps in knowledge and developing new approaches to assist with the transition to personalised medicine. The proposed CRP will build upon the success of a previous IAEA project E35008 on ‘Strengthening of “Biological dosimetry” in IAEA Member States: Improvement of current techniques and intensification of collaboration and networking among the different institutes’ (2012-2016)’. This project will bring together a number of institutions from LMI and HI MSs to progress toward the common goal of improving the quality of health care using radiation technologies.
Objectives
To sustain and enhance the scope of biodosimetry services to radiation oncology, nuclear medicine, diagnostic and interventional radiology.
Specific objectives
Collect biodosimetry data on patients exposed to radiation for medical purposes to fill in knowledge gaps and assist with the transition to personalised medicine.
Establish a research biological dosimetry network for clinical applications.
Propose and test biodosimetry methodology for comprehensive assessment of consequences of medical radiation exposures, including accidental overexposure.
Develop biodosimetry based methods for prediction or prognosis of adverse radiotherapy effects and late complications allowing refinement of radiation treatment plans.
To facilitate dialogue between biodosimetry specialists and radiation oncologists.
To transfer biodosimetry methodology into clinical practice in order to improve outcome of radiation medical services in terms of survival, safety and quality of life.